ECSP992885A - STATIN-MMP INHIBITOR COMBINATIONS - Google Patents

STATIN-MMP INHIBITOR COMBINATIONS

Info

Publication number
ECSP992885A
ECSP992885A ECSP992885A ECSP992885A EC SP992885 A ECSP992885 A EC SP992885A EC SP992885 A ECSP992885 A EC SP992885A EC SP992885 A ECSP992885 A EC SP992885A
Authority
EC
Ecuador
Prior art keywords
statin
mmp inhibitor
inhibitor combinations
combinations
mmp
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Bruce David Roth
Newton Roger Schofierdl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992885 priority Critical patent/ECSP992885A/en
Publication of ECSP992885A publication Critical patent/ECSP992885A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención es una composición farmacéutica que comprende un inhibidor de MMP y una estatina, dicha composición es útil para tratar enfermedades vasculares.This invention is a pharmaceutical composition comprising an MMP inhibitor and a statin, said composition is useful for treating vascular diseases.

ECSP992885 1999-03-16 1999-03-16 STATIN-MMP INHIBITOR COMBINATIONS ECSP992885A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992885 ECSP992885A (en) 1999-03-16 1999-03-16 STATIN-MMP INHIBITOR COMBINATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992885 ECSP992885A (en) 1999-03-16 1999-03-16 STATIN-MMP INHIBITOR COMBINATIONS

Publications (1)

Publication Number Publication Date
ECSP992885A true ECSP992885A (en) 1999-06-11

Family

ID=42043873

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992885 ECSP992885A (en) 1999-03-16 1999-03-16 STATIN-MMP INHIBITOR COMBINATIONS

Country Status (1)

Country Link
EC (1) ECSP992885A (en)

Similar Documents

Publication Publication Date Title
PA8506101A1 (en) USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION
UY25714A1 (en) METHOD FOR TREATING ATHEROSCLEROSIS USING AN AP2 INHIBITOR AND COMBINATION.
BR0317715A (en) Compositions and processes of use of collajolie
DK1373259T3 (en) Pyridazinonal dose reductase inhibitors
PA8522701A1 (en) COMPOUNDS OF BENCENIC ACETAMIDS THAT ARE ACTIVATORS OF GLUCOKINASE a-ACILO-Y a-HETEROATOMO-REPLACED
PA8564901A1 (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE CHOLESTERILE ESTERES TRANSFER PROTEIN
ECSP045520A (en) TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS
BR0113669A (en) Deacetylase Inhibitors
PT1328269E (en) ASSOCIATE OF AN ANTAGONIST OF THE CB1 RECEPTOR AND SIBUTRAMINE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES FOR THE TREATMENT OF OBESITY
ATE380049T1 (en) COMBINATIONS CONTAINING CGMP-PDE5 INHIBITORS.
EE200000766A (en) A pharmaceutical composition comprising a COX-2 inhibitor and an iNOS inhibitor
PT1162969E (en) USE OF DIPEPTIDILPEPTIDASE IV INHIBITORS FOR THE IMPROVEMENT OF FERTILITY
ES2178157T3 (en) TREATMENT OF ARRITMIAS THROUGH THE INHIBITION OF A MULTIFUNCTIONAL KINASE PROTEIN DEPENDENT ON CALCIUM / CALMODULIN.
EE9900028A (en) An anti-thrombotic and anti-atherogenic pharmaceutical composition comprising a thienopyridine derivative and an HMG-CoA reductase inhibitor
GT199800177A (en) EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE.
EP1776954A3 (en) The use of inhibitors of the renin-angiotensin system for the treatment of stroke
PT1032414E (en) COMBINATION OF AN INHIBITOR OF THE ANGIOTENSIN CONVERSATION ENZYME AND A DIURETIC FOR THE TREATMENT OF MICROCIRCULATORY DISTURBACTIONS
AR015837A1 (en) METHOD OF TRANSFORMATION OF PLANTS.
CU20000140A7 (en) STATIN-CARBOXIALQUILETER COMBINATIONS
DOP2000000022A (en) COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES.
MXPA04003365A (en) Combinations comprising cox-2 inhibitors and aspirin.
BR9808923B1 (en) processes for making cyclooxygenase-2 inhibitor compounds, and intermediate compounds for making cyclooxygenase-2 inhibitors.
PT1146897E (en) USING A MELANOMA INHIBITOR ACTIVITY (MIA) FOR CARTILAGE AND BONE REPAIR
PT1301207E (en) COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS CONTAINING A COMPOUND OF OXAZOLIDINONE, SULBACTAM AND AMPICILLIN
IS6087A (en) N- (2-phenyl-4-amino-butyl) -1-naphthamide which acts against neurotransmitter-1 receptors